Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/FCF ratio is N/A as of Wednesday, August 5, 2026.
EV/FCF RATIO
N/A
Market Cap
$2.64B
EV/FCF Ratio
46.08x
TTM Avg
94.45x
3Y Avg
96.60x
5Y Avg
96.60x
Market Cap
$2.76B
EV/FCF Ratio
48.02x
TTM Avg
44.43x
3Y Avg
33.56x
5Y Avg
28.87x
Market Cap
$7.06B
EV/FCF Ratio
108.83x
TTM Avg
90.73x
3Y Avg
73.31x
5Y Avg
73.31x
| NAME | MARKET CAP | EV/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Shoulder Innovations, Inc. (SI) | $468.68M | N/A | N/A | N/A | N/A |
| NRC Health (NRC)vs › | $440.37M | 23.93x | 35.68x | 33.43x | 32.18x |
| 23andMe Holding Co. (ME)vs › | $15.31M | N/A | N/A | N/A | N/A |
| Teladoc Health, Inc. (TDOC)vs › | $1.26B | 6.50x | 7.13x | 9.08x | 16.40x |
| TransMedics Group, Inc. (TMDX)vs › | $2.64B | 46.08x | 94.45x | 96.60x | 96.60x |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $2.76B | 48.02x | 44.43x | 33.56x | 28.87x |
| Hims & Hers Health, Inc. (HIMS)vs › | $7.06B | 108.83x | 90.73x | 73.31x | 73.31x |
| Oscar Health, Inc. (OSCR)vs › | $7.81B | 1.98x | 2.27x | 4.01x | 4.27x |
| Tempus AI, Inc. (TEM)vs › | $8.18B | N/A | N/A | N/A | N/A |
| Insulet Corp. (PODD)vs › | $9.23B | 29.55x | 45.32x | 75.04x | 75.04x |
EV/FCF
N/A
P/FCF
N/A
FCF Yield
N/A
Formula: EV/FCF = Enterprise Value / Free Cash Flow
EV/FCF vs P/FCF:
EV/FCF = Enterprise Value / Free Cash Flow (TTM)
Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
